medigraphic.com
ISSN 1561-2945 (Print)

2020, Number 2

<< Back Next >>

Revista Cubana de Cirugía 2020; 59 (2)

Klatskin's tumor (hilar cholangiocarcinoma) his morbi-mortality in a surgery service

Céspedes RHA, Céspedes RHR, Fernández PR

Language: Spanish
References: 15
Page: 1-11
PDF size: 400.09 Kb.


ABSTRACT

Introduction: Klatskin's tumor is cholangiocarcinoma, most frequent to occur in the bile duct, being responsible for high morbidity and mortality in surgery departments.
Objective: To determine the morbidity and mortality of Klatskin’s tumor at the surgery service of Manuel Ascunce Domenech University Hospital.
Methods: We carried out a descriptive, prospective and observational study of patients admitted to the general surgery service with a diagnosis of Klatskin’s tumor, between September 2018 and January 2020. The study population consisted of seven patients who met the inclusion criteria. Descriptive statistical methods and calculations with percentage values ​​were used.
Results: The highest incidence was represented male and white patients, accounting for 71.4% and 85.7%, respectively. Adenocarcinoma predominated as a histological variety, accounting for 85.7%. There was prevalence of type II of topographic classification, the Hess procedure as the performed operation, and bilirrhagia as a complication, accounting for 42.8%, respectively. 85.7% of the patients were discharged and received surgery for curative purposes.
Conclusions: Most of the patients were male and white. More than half of the patients were classified as types I and II, according to the Bismuth-Corlette classification. The Hess procedure, adenocarcinoma as a histological form, and discharge predominated in all patients.


REFERENCES

  1. Ramia JM. Hilar cholangiocarcinoma. World J Gastrointest Oncol. 2013;5:113-4. DOI: https://doi.org/10.4251/wjgo.v5.i7.113

  2. Suarez-Munoz MA, Fernandez-Aguilar JL, Sanchez Pérez B. Risk factors and classifications of hilar cholangiocarcinoma. World J Gastrointest Oncol. 2013;5:132-8.

  3. Kostov D. Klatskin Tumors. Clinics in Oncology. Published: 29 Dec, 2016. Clin Oncol. 2016;1:1172.

  4. Pellón R, Obregón AL, Trueba HV, Diez ET, Bernal SS, Sánchez FG, et al. Estadificación del tumor de Klatskin con RM. Datos que el cirujano debe saber. European Congress of Radiology-SERAM. 2014. DOI: https://doi.org/10.1594/seram2014/S-0080.

  5. Ahrendt SA, Nakeeb A, Pitt HA: Cholangiocarcinoma. Clin Liver Dis. 2001;5:191.

  6. Lillemoe KD, Cameron JL: Surgery for hilar cholangiocarcinoma: The Johns Hopkins approach. J Hepatobiliary Pancreat Surg. 2000;7:115.

  7. Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastroientest Oncol. 2013;5:139-46. DOI: https://doi.org/10.4251/wjgo.v5.i7.139.

  8. Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Kondo K, et al. Role of hilar resection in the treatment of hilar cholangiocarcinoma. Hepatogastroenterology. 2012;59(115):696-700. DOI: https://doi.org/10.5754/hge09725.

  9. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3(1):18-34. DOI: https://doi.org/10.3978/j.issn.2304-3881.2014.02.05.

  10. Molina V, Sampson J, Ferrer J, Sánchez-Cabus S, Calatayud D, Pavel MC, et al. Tumor de Klatskin: Diagnóstico, evaluación preoperatoria y consideraciones quirúrgicas. Cirugía Española. 2015;93(9):552-60.

  11. Xinying Z, Hui L. Klatskin Tumor: A Population-Based Study of Incidence and Survival. Med Sci Monit, 2019;25: 4503-4512 DOI: https://doi.org/10.12659/MSM.914987.

  12. Sharma P, Yadav S. Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors Annals of Gastroenterology. 2018;31:231-6. DOI: https://doi.org/10.20524/aog.2018.0233.

  13. Van Gulika Thomas M, Ruysa Anthony T, Buscha Oliver RC, Rauwsb Erik AJ, Goumaa Dirk J. Extent of Liver Resection for Hilar Cholangiocarcinoma (Klatskin Tumor): How Much Is Enough? Dig Surg. 2011;28:141-147. DOI: https://doi.org/10.1159/000323825.

  14. Costa S, Henriques AC, Horta S, Waisberg J, Speranzini MB. Indicações e resultados cirúrgicos em vinte e dois doentes com tumor de klatskin. Brasília Med 2010;47(3):326-37.

  15. Poruk Katherine E, Pawlik Timothy M, Weiss Matthew J. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg. 2015;19(10):1889-99. DOI: https://doi.org/10.1007/s11605-015-2854-8.




2020     |     www.medigraphic.com